IDEAS home Printed from https://ideas.repec.org/a/ssi/jouesi/v7y2020i3p1484-1499.html
   My bibliography  Save this article

Scientific priorities and real prospects for cost optimization in formulation development

Author

Listed:
  • Galina T. Glembotskaya

    (I.M. Sechenov First Moscow State Medical University, Russian Federation)

  • Stanislav Yu. Eremin

    (I.M. Sechenov First Moscow State Medical University, Russian Federation)

  • Elena E. Chupandina

    (Voronezh State University, Russian Federation)

Abstract

As a result of the systematic structural analysis of the collected scientific data on the problem under study, the trends in the development of the pharmaceutical sector that have established in the global space, including the Russian Federation, have been marked, the changes in the modern healthcare systems have been noted, and it has been proven that the problem of finding accelerated and efficient methods of drug development that meet the interests of all stakeholders needs the priority solution. The structure of distributing the clinical studies of drugs in the world practice has been presented, and data on the funds for the development of the main stages of the process under study and therapeutic groups of drugs for various nosologies have been presented. The main difficulties of objective assessment of the formulation development costs have been defined, the influencing factors have been identified, and the methodical approach to calculating the resources spent has been proposed. The results have been summarized, and the prospects for the rational use of the advanced information technologies for the development and support of innovative domestic developments in the pharmaceutical sector have been demonstrated. As a result of the research into the scientific data, a real opportunity to optimize the costs of developing innovative drugs through their repositioning has been demonstrated for the first time, the conceptual methodical approach to solving the identified problems has been justified, and prospects for its implementation have been outlined, with due consideration for the further development of the pharmaceutical market and the introduction of personalized pharmaceutical care. The study has been conducted on the basis of systematic analytical structuring of the information data and the results of independent research with the identification of global trends and the determination of practical significance, as well as scientific perspectives in the field under study.

Suggested Citation

  • Galina T. Glembotskaya & Stanislav Yu. Eremin & Elena E. Chupandina, 2020. "Scientific priorities and real prospects for cost optimization in formulation development," Entrepreneurship and Sustainability Issues, VsI Entrepreneurship and Sustainability Center, vol. 7(3), pages 1484-1499, March.
  • Handle: RePEc:ssi:jouesi:v:7:y:2020:i:3:p:1484-1499
    DOI: 10.9770/jesi.2020.7.3(4)
    as

    Download full text from publisher

    File URL: https://jssidoi.org/jesi/uploads/articles/27/Glembotskaya_Scientific_priorities_and_real_prospects_for_cost_optimization_in_formulation_development.pdf
    Download Restriction: no

    File URL: https://jssidoi.org/jesi/article/470
    Download Restriction: no

    File URL: https://libkey.io/10.9770/jesi.2020.7.3(4)?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    drug development; stages of development; efficiency of phases of clinical studies; capabilities of Artificial Intelligence in the development; cost optimization; repositioning of drugs;
    All these keywords.

    JEL classification:

    • O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ssi:jouesi:v:7:y:2020:i:3:p:1484-1499. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Manuela Tvaronaviciene (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.